Brief: Artiva Biotherapeutics Announces Appointment Of Thad Huston As CFO
24/02/2026 13:19
Feb 24 (Reuters) - Artiva Biotherapeutics Inc ARTV.O :
* ARTIVA BIOTHERAPEUTICS ANNOUNCES APPOINTMENT OF THAD
HUSTON AS
CHIEF FINANCIAL OFFICER AND AWARD OF INDUCEMENT GRANT
Source text: ID:nGNX2BWhR5
Further company coverage: ARTV.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Artiva Biotherapeutics
See all newsBrief: Artiva Biotherapeutics Provides Update On Planned Allonk® Data Disclosures And Development Milestones For The Remainder Of 2026
Artiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Artiva Biotherapeutics Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Artiva Biotherapeutics Inc Thad Huston To Separate As CFO Effective May 22, 2026
U.S. STOCKS ON THE MOVE-Corning, BILL Holdings, Moderna